An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study

2021 ◽  
Author(s):  
Adrian L. Lopresti ◽  
Stephen J. Smith ◽  
Peter D. Drummond
Keyword(s):  
Sleep Quality ◽  
Poor Sleep ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Study ◽  
Saffron Extract

scholarly journals Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial

2020 ◽  
Vol 16 (6) ◽  
pp. 937-947 ◽  
Author(s):  
Adrian L. Lopresti ◽  
Stephen J. Smith ◽  
Alexandra P. Metse ◽  
Peter D. Drummond
Keyword(s):  
Sleep Quality ◽  
Controlled Trial ◽  
Healthy Adults ◽  
Poor Sleep ◽  
Double Blind ◽  
Double Blind Placebo

Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

2010 ◽  
Vol 16 (2) ◽  
pp. 233-242 ◽  
Author(s):  
Walter Reinisch ◽  
Williem de Villiers ◽  
László Bene ◽  
László Simon ◽  
István Rácz ◽  
...  
Keyword(s):  
Multiple Dose ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Multiple Dose Study ◽  
Dose Study

A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

2007 ◽  
Vol 104 (2) ◽  
pp. 378-383 ◽  
Author(s):  
Elliott Bennett-Guerrero ◽  
Hilary P. Grocott ◽  
Jerrold H. Levy ◽  
Kevin A. Stierer ◽  
Charles W. Hogue ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Cardiopulmonary Bypass ◽  
Phase Ii ◽  
Lipid A ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Study
Sign in / Sign up

Export Citation Format

Share Document